190 related articles for article (PubMed ID: 22730040)
1. Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan.
Chen SL; Lee SY; Chang YH; Chen SH; Chu CH; Tzeng NS; Lee IH; Chen PS; Yeh TL; Huang SY; Yang YK; Lu RB; Hong JS
J Neuroimmune Pharmacol; 2012 Sep; 7(3):656-64. PubMed ID: 22730040
[TBL] [Abstract][Full Text] [Related]
2. ALDH2 polymorphism, associated with attenuating negative symptoms in patients with schizophrenia treated with add-on dextromethorphan.
Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
J Psychiatr Res; 2015 Oct; 69():50-6. PubMed ID: 26343594
[TBL] [Abstract][Full Text] [Related]
3. The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia.
Zhang L; Zheng H; Wu R; Kosten TR; Zhang XY; Zhao J
Schizophr Res; 2019 Oct; 212():92-98. PubMed ID: 31416745
[TBL] [Abstract][Full Text] [Related]
4. Long-term pharmacoclinical follow-up in schizophrenic patients treated with risperidone. Plasma and red blood cell concentrations of risperidone and its 9-hydroxymetabolite and their relationship to whole blood serotonin and tryptophan, plasma homovanillic acid, 5-hydroxyindoleacetic acid, dihydroxyphenylethyleneglycol and clinical evaluations.
Aymard N; Viala A; Clement MN; Jacquot M; Vacheron MN; Gauillard J; Caroli F
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jun; 26(5):975-88. PubMed ID: 12369274
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of add-on low-dose dextromethorphan plus valproic acid in bipolar disorder.
Chen SL; Lee SY; Chang YH; Chen PS; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1753-9. PubMed ID: 25262178
[TBL] [Abstract][Full Text] [Related]
6. Alteration of Serum Levels of Cytokines in Schizophrenic Patients before and after Treatment with Risperidone.
Azizi E; Zavaran Hosseini A; Soudi S; Noorbala AA
Iran J Allergy Asthma Immunol; 2019 Jun; 18(3):262-268. PubMed ID: 31522433
[TBL] [Abstract][Full Text] [Related]
7. A placebo-controlled trial of dextromethorphan as an adjunct in opioid-dependent patients undergoing methadone maintenance treatment.
Lee SY; Chen SL; Chang YH; Chu CH; Chen SH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv008. PubMed ID: 25716777
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study.
Kudlek Mikulic S; Mihaljevic-Peles A; Sagud M; Bajs Janovic M; Ganoci L; Grubisin J; Kuzman Rojnic M; Vuksan Cusa B; Bradaš Z; Božina N
Nord J Psychiatry; 2017 Oct; 71(7):513-520. PubMed ID: 28671000
[TBL] [Abstract][Full Text] [Related]
9. Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels.
Zhang L; Zheng H; Wu R; Zhu F; Kosten TR; Zhang XY; Zhao J
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():69-76. PubMed ID: 29678772
[TBL] [Abstract][Full Text] [Related]
10. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
Lee BH; Kim YK
Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
[TBL] [Abstract][Full Text] [Related]
12. Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia.
Song X; Fan X; Li X; Zhang W; Gao J; Zhao J; Harrington A; Ziedonis D; Lv L
Psychopharmacology (Berl); 2014 Jan; 231(2):319-25. PubMed ID: 24337064
[TBL] [Abstract][Full Text] [Related]
13. Interaction of BDNF with cytokines in chronic schizophrenia.
Zhang XY; Tan YL; Chen DC; Tan SP; Yang FD; Wu HE; Zunta-Soares GB; Huang XF; Kosten TR; Soares JC
Brain Behav Immun; 2016 Jan; 51():169-175. PubMed ID: 26407757
[TBL] [Abstract][Full Text] [Related]
14. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S
CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia.
Lin CH; Kuo CC; Chou LS; Chen YH; Chen CC; Huang KH; Lane HY
J Clin Psychopharmacol; 2010 Oct; 30(5):518-25. PubMed ID: 20814315
[TBL] [Abstract][Full Text] [Related]
16. Acute and Long-term Memantine Add-on Treatment to Risperidone Improves Cognitive Dysfunction in Patients with Acute and Chronic Schizophrenia.
Schaefer M; Sarkar S; Theophil I; Leopold K; Heinz A; Gallinat J
Pharmacopsychiatry; 2020 Jan; 53(1):21-29. PubMed ID: 31390660
[TBL] [Abstract][Full Text] [Related]
17. Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia.
Müller N; Riedel M; Scheppach C; Brandstätter B; Sokullu S; Krampe K; Ulmschneider M; Engel RR; Möller HJ; Schwarz MJ
Am J Psychiatry; 2002 Jun; 159(6):1029-34. PubMed ID: 12042193
[TBL] [Abstract][Full Text] [Related]
18. Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed - Results from a randomized, double-blind, placebo-controlled clinical trial.
Jahangard L; Akbarian S; Haghighi M; Ahmadpanah M; Keshavarzi A; Bajoghli H; Sadeghi Bahmani D; Holsboer-Trachsler E; Brand S
Psychiatry Res; 2017 May; 251():182-191. PubMed ID: 28213188
[TBL] [Abstract][Full Text] [Related]
19. Dextromethorphan attenuated inflammation and combined opioid use in humans undergoing methadone maintenance treatment.
Chen SL; Lee SY; Tao PL; Chang YH; Chen SH; Chu CH; Chen PS; Lee IH; Yeh TL; Yang YK; Hong JS; Lu RB
J Neuroimmune Pharmacol; 2012 Dec; 7(4):1025-33. PubMed ID: 22990619
[TBL] [Abstract][Full Text] [Related]
20. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
